DexCom Inc. closed 46.96% short of its 52-week high of $142.00, which the company achieved on March 26th.

DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up ...

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...

DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV – Research Report) ...

DexCom, Inc.'s (NASDAQ:DXCM) stock price has dropped 12% in the previous week, but insiders who sold US$16m in stock over the past year have had less luck. The average selling price of US$117 is ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Hence, I have issued a sell rating on the stock. DXCM came up with its 4Q24 results earlier last month. The results were quite muted but were an improvement over even worse results in 3Q24.

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...